Prof Felix Mahfoud gives a brief welcome, outlining the programme agenda and prompting the live audience to share their current access to mechanical thrombectomy and catheter directed devices for PE management.

In this session, Prof Ingo Ahrens discusses the unmet needs in PE care and current risk stratifications, focusing on the gaps for intermediate-high risk patients and the need for structured assessment and rigorous scientific assessment of new reperfusion therapies.

This session explores the current challenges faced in the ICU, and how new therapies could overcome these. Prof Thomas Cuisset discusses the current guidelines and consensus statements, and utilises a patient case study to illustrate and discuss the need for teamwork, robust clinical evidence and optimised risk stratification in PE care.

The faculty discuss risk stratification and decision making in PE management.

The key points of this session by Dr Stefan Stortecky include the history and timeline of randomised evidence in the PE clinical trial landscape, examining the rational and need for these studies, before discussing primary outcomes from PEERLESS, the first randomised clinical trial evaluating mechanical thrombectomy vs catheter directed thrombolysis.

In this session, Dr Jay Giri offers insights into the future landscape of care for PE patients. 

The faculty engage in an interactive discussion on navigating the clinical evidence.

Prof Felix Mahfoud concludes the webinar with key reflections and a final audience poll to assess potential changes in their PE management practices.